Related Experiment Video
Updated: Oct 1, 2025
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies
Vahideh Keyvani1,2, Espanta Riahi3, Meysam Yousefi4
1Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Abstract:
Gynecologic cancer is one of the main causes of death in women. In this type of cancer, several molecules (oncogenes or tumor suppressor genes) contribute to the tumorigenic process, invasion, metastasis, and resistance to treatment. Based on recent evidence, the detection of molecular changes in these genes could have clinical importance for the early detection and evaluation of tumor grade, as well as the selection of targeted treatment. Researchers have recently focused on cancer stem cells (CSCs) in the treatment of gynecologic cancer because of their ability to induce progression and recurrence of malignancy. This has highlighted the importance of a better understanding of the molecular basis of CSCs. The purpose of this review is to focus on the molecular mechanism of gynecologic cancer and the role of CSCs to discover more specific therapeutic approaches to gynecologic cancer treatment.
Insights
Gynecologic cancers involve molecular changes in oncogenes and tumor suppressor genes. Understanding cancer stem cells (CSCs) is crucial for developing targeted therapies against these deadly women's cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gynecologic cancers are a leading cause of death in women.
- Tumorigenesis, invasion, metastasis, and treatment resistance involve key molecular alterations.
- Cancer stem cells (CSCs) drive gynecologic cancer progression and recurrence.
Purpose of the Study:
- To review the molecular mechanisms underlying gynecologic cancers.
- To explore the role of CSCs in gynecologic cancer development.
- To identify novel therapeutic strategies targeting molecular pathways and CSCs.
Main Methods:
- Literature review of molecular mechanisms in gynecologic cancers.
- Analysis of the role of oncogenes and tumor suppressor genes.
- Examination of CSC biology and its implications for treatment.
Main Results:
- Specific molecular changes correlate with tumor grade and treatment response.
- CSCs are key drivers of gynecologic cancer progression and recurrence.
- Targeting molecular pathways and CSCs offers potential for improved therapies.
Conclusions:
- Understanding molecular alterations and CSCs is vital for early detection and personalized treatment.
- Targeted therapies based on molecular profiling and CSCs may enhance gynecologic cancer outcomes.
- Further research into CSC-specific molecular targets is warranted.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:18Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:19Mesenchymal Stem Cells